Search Results 1771-1780 of 20439 for hepatitis

1. A Study to Evaluate CB-839 With Radiation Therapy and Temozolomide in Treating Participants With IDH-Mutated Diffuse Astrocytoma or Anaplastic Astrocytoma - Mayo Clinic

   If there is history of hepatitis C virus (HCV) infection, patients must have been treated and HCV viral load must be undetectable. Patient must have ...

2. A Study of MTI-301 in Patients with Advanced Malignancy - Mayo Clinic

   ... Hepatitis B and C on active treatment, or those with acute hepatitis B and C not currently on treatment. NOTE: Patients known to be HIV positive, but ...

3. Nivolumab in Treating Patients With Relapsed or Refractory Peripheral T-cell Lymphoma - Mayo Clinic

   ... hepatitis B virus surface antigen (HBV sAg+), active hepatitis C (if Ab+ then PCR+) indicating acute or chronic infection; Uncontrolled intercurrent illness ...

4. Study to Test the Safety and Tolerability of PF-07257876 in Participants with Selected Advanced Tumors - Mayo Clinic

   ... Hepatitis B, Hepatitis C, or Human immunodeficiency virus (HIV) infection - Active COVID-19/SARS-CoV2 - Pregnant or breastfeeding female participant - Organ ...

5. A Randomized Trial of Pembrolizumab & Radiotherapy Versus Radiotherapy in High-Risk Soft Tissue Sarcoma of the Extremity - Mayo Clinic

   Known active Hepatitis B (e.g., HBsAg reactive, confirmed by detectable viral load) or Hepatitis C (e.g., HCV RNA [qualitative] detected). Received a live ...

6. DeeDee Stiepan | Mayo Clinic News Network - Page 10 of 25

   Several countries, including the U.S., have identified or are investigating unexplained hepatitis cases in children. While the reported cases are appearing ...

7. Transplant Medicine Physicians - Medical Professionals - Mayo Clinic

   ... hepatitis, Autoimmune hepatitis, Acute liver failure, Kidney failure, Fatty liver disease, End-stage liver disease, Kidney disease ...

8. Dr. Lionel Kankeu Fonkoua – diversity in clinical trials

   His study focuses on the immigrant African and Asian communities of Minnesota with a high prevalence of hepatitis-induced hepatocellular carcinoma — a type of.

9. Open-Label Study of the CDK4/6 Inhibitor SPH4336 in Subjects With Locally Advanced or Metastatic Liposarcomas - Mayo Clinic

   Known hepatitis B virus (HBV) or hepatitis C virus (HCV) infection with viral load above the limit of quantification. Active COVID-19 infection. Major ...

10. Ibrutinib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Ineligible for Transplant - Mayo Clinic

    Known hepatitis B or hepatitis C infection; EXCEPTION: if viral load < 800,000 IU/L; Phase I: active dermatologic disease >= grade 3. Participating Mayo ...